List of publications

All the publications of the C3M teams.

Export in CSV
In vivo CAR T cell therapy against angioimmunoblastic T cell lymphoma.

Authors Krug A, Saidane A, Martinello C, Fusil F, Michels A, Buchholz CJ, Ricci JE, Verhoeyen E

Journal of experimental & clinical cancer research : CR Sep 2024

RAC2 gain-of-function variants causing inborn error of immunity drive NLRP3 inflammasome activation.

Authors Doye A, Chaintreuil P, Lagresle-Peyrou C, Batistic L, Marion V, Munro P, Loubatier C, Chirara R, Sorel N, Bessot B, Bronnec P, Contenti J, Courjon J, Giordanengo V, Jacquel A, Barbry P, Couralet M, Aladjidi N, Fischer A, Cavazzana M, Mallebranche C, Visvikis O, Kracker S, Moshous D, Verhoeyen E, Boyer L

The Journal of experimental medicine Aug 2024

Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.

Authors Proteau S, Krossa I, Husser C, Guéguinou M, Sella F, Bille K, Irondelle M, Dalmasso M, Barouillet T, Cheli Y, Pisibon C, Arrighi N, Nahon-Estève S, Martel A, Gastaud L, Lassalle S, Mignen O, Brest P, Mazure NM, Bost F, Baillif S, Landreville S, Turcotte S, Hasson D, Carcamo S, Vandier C, Bernstein E, Yvan-Charvet L, Levesque MP, Ballotti R, Bertolotto C, Strub T

EMBO molecular medicine Aug 2024

Vitiligo auto-immune response upon oxidative stress-related mitochondrial DNA release opens up new therapeutic strategies.

Authors Sant'Anna-Silva ACB, Botton T, Rossi A, Dobner J, Bzioueche H, Thach N, Blot L, Pagnotta S, Kleszczynski K, Steinbrink K, Mazure NM, Rocchi S, Krutmann J, Passeron T, Tulic MK

Clinical and translational medicine Aug 2024

HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma.

Authors Contenti J, Guo Y, Larcher M, Mirabal-Ortega L, Rouleau M, Irondelle M, Tiroille V, Mazzu A, Duranton-Tanneur V, Pedeutour F, Ben-Sahra I, Lago C, Leva G, Tiberi L, Robert G, Pouponnot C, Bost F, Mazure NM

Cell death discovery Jul 2024

Loss of LYN is frequent in targeted-therapy resistant melanoma cells and favors metastatic properties.

Authors Gaudel C, Pisibon C, Soysouvanh F, Giuliano S, Picard-Gauci A, Leclerc J, Hofman P, Bahadoran P, Bertolotto C, Ballotti R

The Journal of investigative dermatology Jul 2024

The marine-derived HIF-1α inhibitor, Yardenone 2, reduces prostate cancer cell proliferation by targeting HIF-1 target genes.

Authors Peng S, Guo Y, Irondelle M, Mazzu A, Kahi M, Ferreira Montenegro P, Bost F, Mazure NM

Cellular & molecular biology letters Jul 2024

Emerging role of glutathione peroxidase 4 in myeloid cell lineage development and acute myeloid leukemia.

Authors Auberger P, Favreau C, Savy C, Jacquel A, Robert G

Cellular & molecular biology letters Jul 2024

Fructooligosaccharides benefits on glucose homeostasis upon high-fat diet feeding require type 2 conventional dendritic cells.

Authors Gélineau A, Marcelin G, Ouhachi M, Dussaud S, Voland L, Manuel R, Baba I, Rouault C, Yvan-Charvet L, Clément K, Tussiwand R, Huby T, Gautier EL

Nature communications Jun 2024

Dependence on mitochondrial respiration of malignant T cells reveals a new therapeutic target for angioimmunoblastic T-cell lymphoma.

Authors Krug A, Mhaidly R, Tosolini M, Mondragon L, Tari G, Turtos AM, Paul-Bellon R, Asnafi V, Marchetti S, Di Mascio L, Travert M, Bost F, Bachy E, Argüello RJ, Fournié JJ, Gaulard P, Lemonnier F, Ricci JE, Verhoeyen E

Cell death discovery Jun 2024